Synthesis of "glycospirostanes" via ring-closing metathesis

Steroids

Volumn 74, Issue 13-14, 2009, Pages 1073-1079

  Czajkowska, Dorota ^a   Morzycki, Jacek W ^a   Santillan, Rosa ^b   Siergiejczyk, Leszek ^a  

^a UNIVERSITY OF BIALYSTOK   (Poland)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

Glycospirostanes; Polyhydroxylated compounds; Ring closing metathesis

Indexed keywords

27 NOR 5ALPHA FUROST 25 EN 3BETA,22 DIOL; 27 NOR 5ALPHA SPIROST 24 EN 3BETA OL T BUTYLDIMETHYLSILYL ETHER; 27 NOR 5ALPHA SPIROST 3BETA,23,24,25 TETRAOL; 27 NOR 5BETA SPIROST 24 EN 3ALPHA OL T BUTYLDIMETHYLSILYL; 27 NOR 5BETA SPIROST 3ALPHA,23,24,25 TETRAOL; 3ALPHA HYDROXY 23,24 DINOR 5BETA CHOLANO 22,16 LACTONE; 3ALPHA T BUTYLDIMETHYLSILYLOXY 22 ALLYLOXY 26,27 DINOR 5BETA FUROST 24 EN 22 OL; 3ALPHA T BUTYLDIMETHYLSILYLOXY 23,24 DINOR 5BETA CHOLANO 22,16 LACTONE; 3ALPHA T BUTYLDIMETHYLSILYLOXY 26,27 DINOR 5BETA FUROST 24 EN 22 OL; 3ALPHA T BUTYLDIMETHYLSILYLOXY 27 NOR 5BETA SPIROST 24 EN 23 OL; 3BETA HYDROXY 23,24 DINOR 5ALPHA CHOLANO 22,16 LACTONE; 3BETA T BUTYLDIMETHYLSILYLOXY 22 ALLYLOXY 26,27 DINOR 5ALPHA FUROST 24 EN 22 OL; 3BETA T BUTYLDIMETHYLSILYLOXY 23,24 DINOR 5ALPHA CHOLANO 22,16 LACTONE; 3BETA T BUTYLDIMETHYLSILYLOXY 26,27 DINOR 5ALPHA FUROST 24 EN 22 OL; 3BETA T BUTYLDIMETHYLSILYLOXY 27 NOR 5ALPHA SPIROST 23,24,25 TRIOL; 3BETA T BUTYLDIMETHYLSILYLOXY 27 NOR 5ALPHA SPIROST 24 EN 23 OL; GLYCOSPIROSTANE; SPIROSTAN DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CRYSTAL STRUCTURE; DRUG STRUCTURE; DRUG SYNTHESIS; HYDROXYLATION; RING CLOSING METATHESIS;

NORSTEROIDS; SPIROSTANS;

EID: 70350566170     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.steroids.2009.09.001     Document Type: Article

References (15)

1. Rosenkranz G., Pataki J., and Djerassi C. Steroids. XXV. Synthesis of cortisone. J Am Chem Soc 73 (1951) 4055-4056
2. Marker R.E., Wagner R.B., Ulshafer P.R., Wittbecker E.L., Goldsmith D.P.J., and Ruof C.H. Steroidal sapogenins. J Am Chem Soc 69 (1947) 2167-2230
3. Sparg S.G., Light M.E., and van Staden J. Biological activities and distribution of plant saponins. J Ethnopharmacol 94 (2004) 219-243
4. Simões C.M.O., Amoros M., and Girre L. Mechanism of antiviral activity of triterpenoid saponins. Phytother Res 13 (1999) 323-328
5. Killeen G.F., Madigan C.A., Connolly C.R., Walsh G.A., Clark C., Hynes M.J., et al. Antimicrobial saponins of Yucca schidigera and the implications of their in vitro properties for their in vivo impact. J Agric Food Chem 46 (1998) 3178-3186
6. Sindambiwe J.B., Calomme M., Geerts S., Pieters L., Vlietinck A.J., and Vanden Berghe D.A. Evaluation of biological activities of triterpenoid saponins from Maesa lanceolata. J Nat Prod 61 (1998) 585-590
7. Li D.W., Lee E.B., Kang S.S., Hyun J.E., and Whang W.K. Activity-guided isolation of saponins from Kalopanax pictus with anti-inflammatory activity. Chem Pharm Bull 50 (2002) 900-903
8. Itabashi M., Segawa K., Ikeda Y., Kondo S., Naganawa H., Koyano T., et al. A new bioactive steroidal saponin, furcreastatin, from the plant Furcraea foetida. Carbohydr Res 323 (1999) 57-62
9. López Y., Jastrze{ogonek}bska I., Santillan R., and Morzycki J.W. Synthesis of "glycospirostanes"-steroid sapogenins with a sugar-like ring F. Steroids 73 (2008) 449-457
10. Altomare A., Cascarano G., Giacovazzo C., and Guagliardi A. Completion and refinement of crystal structures with SIR92. J Appl Crystallogr 26 (1993) 343-350
11. Sheldrick G.M. SHELXL-97. A program for the refinement of crystal structure (1997), University of Göttingen, Germany
12. 2 from diosgenin. Tetrahedron 64 (2008) 469-476
13. Ghosh S.K., Ko C., Liu J., Wang J., and Hsung R.P. A ketal-tethered RCM strategy toward the synthesis of spiroketal related natural products. Tetrahedron 62 (2006) 10485-10496
14. Iglesias-Arteaga MA, Velázquez-Huerta GA, Méndez-Stivalet JM, Galano A, Alvarez-Idaboy JR, The Baeyer-Villiger reaction of 23-oxosapogenins. Arkivoc 2005; VI:109-126.
15. 13C NMR spectra of steroidal sapogenins: smilagenin and sarsasapogenin. Magn Reson Chem 35 (1997) 441-446